Neogen (NASDAQ:NEOG) Shares Gap Down - Should You Sell?

Key Points

• Beat but profitability concern: Neogen beat Q3 estimates (EPS $0.09 vs. $0.04; revenue $211.2M vs. $204.6M) but revenue was down ~4.4% YoY and the company reported a materially negative net margin (~-68%), indicating one‑time charges or restructuring hurt near‑term profitability.
• Shares gap down and mixed outlook: The stock gapped down premarket (closed $10.34 → opened $9.20; trading near $10.16) as investors reacted to profitability and segment issues, while analyst coverage is mixed with a consensus “Hold” and an average price target of $10.67 amid ~97% institutional ownership.

Neogen Corporation (NASDAQ:NEOG - Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $10.34, but opened at $9.20. Neogen shares last traded at $10.16, with a volume of 1,427,083 shares.

Key Stories Impacting Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Q3 beat on both EPS and revenue versus consensus (EPS $0.09 vs. $0.04 est.; revenue $211.2M vs. $204.6M est.), showing the company outperformed near-term Street expectations. Neogen (NEOG) Beats Q3 Earnings and Revenue Estimates MarketBeat Earnings Release
• Neutral Sentiment: Company released the full Q3 press release, slide deck and hosted a conference call outlining a strategic transformation and updated FY-2026 guidance — useful for clarifying drivers but not decisive on its own. Neogen Reports Third Quarter Fiscal Year 2026 Financial Results Slide Deck
• Neutral Sentiment: Corporate governance update: appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer — likely stability/controls positive but not material short-term. Appointment Announcement
• Negative Sentiment: Despite the beat, investors focused on weakening profitability: revenue was down ~4.4% YoY and the company reported a materially negative net margin (reported -68% in the release), suggesting one-time charges or restructuring hit results and raising questions about near-term profitability recovery. MarketBeat Earnings Details
• Negative Sentiment: Sector/segment drag: coverage (Barron’s) notes the Animal Safety business is facing “third‑party” setbacks that are weighing on results and investor confidence — this helps explain why the stock fell despite the top-line and EPS beats. Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren't Helping.

Analyst Upgrades and Downgrades

Several brokerages recently commented on NEOG. Piper Sandler reissued a "neutral" rating and issued a $10.00 price target (up from $6.50) on shares of Neogen in a report on Monday, January 12th. Weiss Ratings reissued a "sell (e+)" rating on shares of Neogen in a report on Monday, December 29th. CJS Securities raised shares of Neogen from a "market perform" rating to an "outperform" rating and set a $10.00 price target for the company in a report on Wednesday, December 10th. Guggenheim reissued a "buy" rating and issued a $12.00 price target (up from $8.00) on shares of Neogen in a report on Friday, January 9th. Finally, Wall Street Zen raised shares of Neogen from a "hold" rating to a "buy" rating in a report on Saturday, February 14th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Neogen presently has a consensus rating of "Hold" and an average price target of $10.67.

Neogen Price Performance

The firm has a market cap of $2.22 billion, a PE ratio of -3.68 and a beta of 1.97. The stock's fifty day moving average price is $10.09 and its 200-day moving average price is $7.97. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.91 and a quick ratio of 2.80.

Neogen (NASDAQ:NEOG - Get Free Report) last released its earnings results on Thursday, April 9th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.05. The business had revenue of $211.20 million during the quarter, compared to analyst estimates of $204.62 million. Neogen had a negative net margin of 68.47% and a positive return on equity of 2.14%. The business's revenue was down 4.4% compared to the same quarter last year. As a group, equities analysts expect that Neogen Corporation will post 0.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of NEOG. AQR Capital Management LLC boosted its position in shares of Neogen by 217.0% during the 1st quarter. AQR Capital Management LLC now owns 52,410 shares of the company's stock valued at $443,000 after acquiring an additional 35,878 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Neogen by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company's stock valued at $1,125,000 after acquiring an additional 5,638 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Neogen by 5,687.3% during the 1st quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company's stock valued at $290,000 after acquiring an additional 32,816 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Neogen by 14.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company's stock valued at $14,553,000 after acquiring an additional 209,990 shares during the last quarter. Finally, United Services Automobile Association acquired a new position in Neogen in the first quarter valued at about $112,000. Institutional investors and hedge funds own 96.73% of the company's stock.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen's product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.